Cerebral Arteriovenous Malformations Viewpoint: Endovascular Therapy Perspective

  • M. Yashar S. Kalani
  • Richard W. Williamson
  • Felipe C. Albuquerque
  • Cameron G. McDougal


Arteriovenous malformations (AVMs) are rare lesions with aggressive natural histories that predispose the patients, who are generally young at the time of diagnosis, to a lifetime of hemorrhage risk. The recent publication of the ARUBA trial has further complicated the decision tree for management of unruptured AVMs. AVMs require the availability of a comprehensive neurovascular service with expertise in neurosurgery, interventional neuroradiology, and radiation therapy. The decision to treat an AVM should rest upon an understanding of the natural history of these lesions as well as morbidity and mortality associated with treatment. This chapter summarizes the indications and outcomes of endovascular treatment of AVMs.


Arteriovenous Malformation Endovascular Embolization Angiographic Feature Strict Blood Pressure Control Arterial Pedicle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Lasjaunias P, Berenstein A, ter Brugge K. Clinical vascular anatomy and variations, Surgical neuroangiography. Berlin: Springer; 2001.CrossRefGoogle Scholar
  2. 2.
    Fujimura M, Kimura N, Ezura M, Niizuma K, Uenohara H, Tominaga T. Development of a de novo arteriovenous malformation after bilateral revascularization surgery in a child with moyamoya disease. J Neurosurg Pediatr. 2014;13(6):647–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Stevens J, Leach JL, Abruzzo T, Jones BV. De novo cerebral arteriovenous malformation: case report and literature review. AJNR Am J Neuroradiol. 2009;30(1):111–2.CrossRefPubMedGoogle Scholar
  4. 4.
    Mohr JP, Parides MK, Stapf C, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917):614–21.PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Hofmeister C, Stapf C, Hartmann A, et al. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke. 2000;31(6):1307–10.CrossRefPubMedGoogle Scholar
  6. 6.
    Hernesniemi JA, Dashti R, Juvela S, Vaart K, Niemela M, Laakso A. Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery. 2008;63(5):823–9; discussion 829–31.CrossRefPubMedGoogle Scholar
  7. 7.
    Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg. 1990;73(3):387–91.CrossRefPubMedGoogle Scholar
  8. 8.
    Itoyama Y, Uemura S, Ushio Y, et al. Natural course of unoperated intracranial arteriovenous malformations: study of 50 cases. J Neurosurg. 1989;71(6):805–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Laakso A, Dashti R, Juvela S, Isarakul P, Niemela M, Hernesniemi J. Risk of hemorrhage in patients with untreated Spetzler-Martin grade IV and V arteriovenous malformations: a long-term follow-up study in 63 patients. Neurosurgery. 2011;68(2):372–7; discussion 378.CrossRefPubMedGoogle Scholar
  10. 10.
    Laakso A, Hernesniemi J. Arteriovenous malformations: epidemiology and clinical presentation. Neurosurg Clin N Am. 2012;23(1):1–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Lawton MT, Abla AA. Management of brain arteriovenous malformations. Lancet. 2014;383(9929):1634–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Russin J, Spetzler R. Commentary: The ARUBA trial. Neurosurgery. 2014;75(1):E96–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65(4):476–83.CrossRefPubMedGoogle Scholar
  14. 14.
    Hamilton MG, Spetzler RF. The prospective application of a grading system for arteriovenous malformations. Neurosurgery. 1994;34(1):2–6; discussion 6–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Spetzler RF, Ponce FA. A 3-tier classification of cerebral arteriovenous malformations. Clinical article. J Neurosurg. 2011;114(3):842–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Chang SD, Marcellus ML, Marks MP, Levy RP, Do HM, Steinberg GK. Multimodality treatment of giant intracranial arteriovenous malformations. Neurosurgery. 2007;61(1 Suppl):432–42; discussion 442–434.PubMedGoogle Scholar
  17. 17.
    Pandey P, Marks MP, Harraher CD, et al. Multimodality management of Spetzler-Martin Grade III arteriovenous malformations. J Neurosurg. 2012;116(6):1279–88.CrossRefPubMedGoogle Scholar
  18. 18.
    Saatci I, Geyik S, Yavuz K, Cekirge HS. Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique: long-term results in 350 consecutive patients with completed endovascular treatment course. J Neurosurg. 2011;115(1):78–88.CrossRefPubMedGoogle Scholar
  19. 19.
    Yu SC, Chan MS, Lam JM, Tam PH, Poon WS. Complete obliteration of intracranial arteriovenous malformation with endovascular cyanoacrylate embolization: initial success and rate of permanent cure. AJNR Am J Neuroradiol. 2004;25(7):1139–43.PubMedGoogle Scholar
  20. 20.
    Natarajan SK, Ghodke B, Britz GW, Born DE, Sekhar LN. Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances. Neurosurgery. 2008;62(6):1213–25; discussion 1225–16.CrossRefPubMedGoogle Scholar
  21. 21.
    Starke RM, Meyers PM, Connolly ES. Adjuvant endovascular management of brain arteriovenous malformations. In: Youmans JR, Winn HR, editors. Youmans neurological surgery. Philadelphia: Elsevier; 2011. p. 4058.Google Scholar
  22. 22.
    van Rooij WJ, Jacobs S, Sluzewski M, van der Pol B, Beute GN, Sprengers ME. Curative embolization of brain arteriovenous malformations with onyx: patient selection, embolization technique, and results. AJNR Am J Neuroradiol. 2012;33(7):1299–304.CrossRefPubMedGoogle Scholar
  23. 23.
    Andrade-Souza YM, Ramani M, Beachey DJ, et al. Liquid embolisation material reduces the delivered radiation dose: a physical experiment. Acta Neurochir. 2008;150(2):161–4; discussion 164.CrossRefPubMedGoogle Scholar
  24. 24.
    Kano H, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for arteriovenous malformations after embolization: a case-control study. J Neurosurg. 2012;117(2):265–75.CrossRefPubMedGoogle Scholar
  25. 25.
    Schwyzer L, Yen CP, Evans A, Zavoian S, Steiner L. Long-term results of gamma knife surgery for partially embolized arteriovenous malformations. Neurosurgery. 2012;71(6):1139–47; discussion 1147–38.CrossRefPubMedGoogle Scholar
  26. 26.
    Shtraus N, Schifter D, Corn BW, et al. Radiosurgical treatment planning of AVM following embolization with Onyx: possible dosage error in treatment planning can be averted. J Neurooncol. 2010;98(2):271–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Blackburn SL, Ashley Jr WW, Rich KM, et al. Combined endovascular embolization and stereotactic radiosurgery in the treatment of large arteriovenous malformations. J Neurosurg. 2011;114(6):1758–67.CrossRefPubMedGoogle Scholar
  28. 28.
    Brown Jr RD, Wiebers DO, Forbes GS. Unruptured intracranial aneurysms and arteriovenous malformations: frequency of intracranial hemorrhage and relationship of lesions. J Neurosurg. 1990;73(6):859–63.CrossRefPubMedGoogle Scholar
  29. 29.
    da Costa L, Wallace MC, Ter Brugge KG, O’Kelly C, Willinsky RA, Tymianski M. The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke. 2009;40(1):100–5.CrossRefPubMedGoogle Scholar
  30. 30.
    Kader A, Young WL, Pile-Spellman J, et al. The influence of hemodynamic and anatomic factors on hemorrhage from cerebral arteriovenous malformations. Neurosurgery. 1994;34(5):801–7; discussion 807–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Krings T, Hans FJ, Geibprasert S, Terbrugge K. Partial “targeted” embolisation of brain arteriovenous malformations. Eur Radiol. 2010;20(11):2723–31.PubMedCentralCrossRefPubMedGoogle Scholar
  32. 32.
    Han PP, Ponce FA, Spetzler RF. Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm. J Neurosurg. 2003;98(1):3–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Batjer HH, Devous Sr MD, Seibert GB, et al. Intracranial arteriovenous malformation: relationships between clinical and radiographic factors and ipsilateral steal severity. Neurosurgery. 1988;23(3):322–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Kusske JA, Kelly WA. Embolization and reduction of the “steal” syndrome in cerebral arteriovenous malformations. J Neurosurg. 1974;40(3):313–21.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • M. Yashar S. Kalani
    • 1
  • Richard W. Williamson
    • 1
  • Felipe C. Albuquerque
    • 1
  • Cameron G. McDougal
    • 1
  1. 1.Division of Neurological SurgeryBarrow Neurological Institute, St. Joseph’s Hospital and Medical CenterPhoenixUSA

Personalised recommendations